|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Cervical disc disorder w radiculopathy, mid-cervical region
ICD-10 (CM) Code and Descriptor
|
M50.121 |
Cervical disc disorder at C4-C5 level with radiculopathy
|
M50121 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 38.71%
|
25.10%
|
13.79%
|
8.05%
|
4.71%
|
3.21%
|
1.73%
|
0.93%
|
0.75%
|
0.88%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M50.121*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,897
|
5,179
|
|
72141
|
MRI NECK SPINE W/O DYE |
1,274
|
1,274
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
1,049
|
5,128
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,048
|
10,312
|
|
J3010
|
FENTANYL CITRATE INJECTION |
973
|
2,014
|
|
C1713
|
ANCHOR/SCREW BN/BN,TIS/BN |
898
|
5,688
|
|
97110
|
THERAPEUTIC EXERCISES |
847
|
1,419
|
|
J2405
|
ONDANSETRON HCL INJECTION |
814
|
3,708
|
|
22853
|
INSJ BIOMECHANICAL DEVICE |
810
|
937
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
802
|
45,249
|
|
22551
|
ARTHRD ANT NTRBDY CERVICAL |
761
|
944
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
714
|
1,000
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
703
|
1,478
|
|
J1170
|
HYDROMORPHONE INJECTION |
700
|
1,325
|
|
72040
|
X-RAY EXAM NECK SPINE 2-3 VW |
659
|
670
|
|
22552
|
ARTHRD ANT NTRBD CERVICAL EA |
599
|
655
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
572
|
576
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
488
|
6,788
|
|
62321
|
NJX INTERLAMINAR CRV/THRC |
466
|
466
|
|
97530
|
THERAPEUTIC ACTIVITIES |
428
|
609
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M50.121 related to the following DRG Codes:
551-552
|
